期刊文献+

口服戊酸雌二醇对自然更年期大鼠超敏C反应蛋白的影响 被引量:2

Effect of oral estradiol valerate on the high sensitivity C-reactive protein in climacteric SD rats
下载PDF
导出
摘要 目的探讨口服戊酸雌二醇对自然更年期雌性SD大鼠超敏C反应蛋白(high sensitivity C-reactive protein,hs-CRP)及白介素-6(interleukin-6,IL-6)水平的影响。方法将70只15月龄雌性SD大鼠采用数字表法随机分为实验组和对照组,实验组进行戊酸雌二醇灌胃给药,对照组给予等量0.9%氯化钠注射液,14周腹主动脉采血,测定血清超敏C反应蛋白与白介素-6水平。结果实验组血清hs-CRP水平明显低于对照组(P<0.05),实验组血清IL-6水平较对照组有降低趋势,但差异无统计学意义(P>0.05)。结论口服戊酸雌二醇可以降低血清hs-CRP的水平,对心血管疾病起到一个积极的保护作用。 Objective To investigate the effects of estrogen on the high sensitivity C-reactive protein (hs-CRP), IL-6. Methods Seventy SPF female SD rats, fifteen-month-old, were randomly divided into two groups by digital table method: treatment group and control group. The treatment group was given estradiol valerate orally, once per day, the control group was orally fed with physiological saline intragastric administration, once per day, fourteen weeks. After the treatment, blood samples were taken from the rats to assess the level of hs-CRP, IL-6. Results Fourteen weeks after intragastric administration, in the treatment group, serum hs-CRP level was lower than that in the control group(P〈0.05) ; while the IL-6 level was lower than that in control group(P〉O. 05). Conclusion Intragastric administration of estradiol valerate might decrease the hs-CRP, so estradiol may play a positive protective role in cardiovascular disease prevention.
出处 《首都医科大学学报》 CAS 2013年第4期501-505,共5页 Journal of Capital Medical University
基金 国家自然科学基金项目(30872745) 北京市卫生系统高层次人才资助项目(2009-3-52)~~
关键词 戊酸雌二醇 自然更年期大鼠 灌胃 超敏C反应蛋白 白介素-6 心血管疾病 estradiol valerate climacteric SD rats intragastric administration high sensitivity C-reactive protein (hs-CRP) interleukin-6 (IL-6) cardiovascular disease
  • 相关文献

参考文献24

  • 1Mosca L, Collins P, Herrington D M, et al. Hormone re?placement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Associ?ation] 1]. Circulation, 2001, 104( 4) :499-503.
  • 2Makela R, Dastidar P,Jokela H, et al. Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to myeloperoxidase pro?moter polymorphism[J].J Clin Endocrinol Metab, 2003, 88(8) :3823-3828.
  • 3Libby P, Ridker PM, Maseri A. Inflammation and athero?sclerosis] 1]. Circulation, 2002,105 (9) : 1135-1143.
  • 4Bassuk 5 5, Rifai N, Ridker P M. High-sensitivity C-reac?tive protein: clinical importance[J]. Curr Probl Cardiol, 2004,29(8):439-493.
  • 5Libby P, Ridker P M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment[J]. AmJ Med, 2004,116(suppl. 6A) :95-165.
  • 6Kishimoto T. IL-6 from its discovery to clinical applications[J]. Int Immunol, 2010,22(5) :347-352.
  • 7Emerging Risk Factors Collaboration, Kaptoge 5, Di An?gelantonio E, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction[J] . N EnglJ Med, 2012,367(14) :1310-1320.
  • 8施新酞.医学动物实验学[M].西安:陕西科学技术出版社,1989:418-420.
  • 9Marcondes F K, Bianchi FJ, Tanno A P. Determination of the estrous cycle phases of rats: some helpful considerations [J]. BrazJ BioI, 2002,62(4A) :609-1i14.
  • 10Ziegler DR, Gallagher M. Spatial memory in middle-aged female ratsj Assessment of estrogen replacement after ovari?ectomy[J]. Brain Res, 2005,1052(2) :163-173.

二级参考文献47

  • 1王曦云,孙雨时,赵云学,揣丽梅.原发性高血压与抗心磷脂抗体及高敏C-反应蛋白相关性研究[J].中国心血管病研究,2006,4(10):743-745. 被引量:11
  • 2李秀娟,王亚南,范侠,唐利龙.高敏C-反应蛋白及其在心血管疾病中的临床意义[J].心血管病学进展,2007,28(1):92-96. 被引量:25
  • 3赵晓琴,王瑞英,许志红.运动血压与高敏-C反应蛋白、血管内皮功能的相关性研究[J].中国心血管病研究,2007,5(4):278-281. 被引量:2
  • 4Gaede P,Lund-Andersen H,Parving HH,et al.Effect of a multifactorial intervention on mortality in type2diabetes[J].N Engl J Med,2008,358(6):580-591.
  • 5Ridker PM,Buring JE,Rifai N,et al.Development and validation of improved algorithms for the assessment of global cardiovascular risk in women:the Reynolds Risk Score[J].JAMA,2007,297(6):611-619.
  • 6Nambi V,Hoogeveen RC,Chambless L,et al.Lipopro-tein-associated phospholipase A2and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities(ARIC)study[J].Stroke,2009,40(2):376-381.
  • 7Ross R.Atherosclerosis-an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
  • 8Mizuno Y,Jacob RF,Mason RP.Inflammation and the de-velopment of atherosclerosis[J].J Atheroscler Throm,2011,18(5):351-358.
  • 9Roque M,Kim WJ,Gazdoin M,et al.CCR2deficiency de-creases intimal hyperplasia after arterial iniury[J].Arterioscler Thromb Vasc Biol,2002,22(4):554-559.
  • 10Mestas J,Ley K.Monocyte-endothelial cell interactions in the development of atherosclerosis[J].Trends Cardiovasc Med,2008,18(6):228-232.

共引文献10

同被引文献22

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部